Brief: IGC Announces Issuance Of Patent For Treatment Of Alzheimer's Disease Using THC
22/07/2021 12:10
July 22 (Reuters) - India Globalization Capital Inc IGC.A :
* IGC ANNOUNCES ISSUANCE OF PATENT FOR THE TREATMENT OF
ALZHEIMER’S DISEASE USING THC
Source text for Eikon: ID:nBw81m5pka
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment